Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies

Journal of Neural Transmission

Volumn 112, Issue 4, 2005, Pages 557-563

  Molina, J A ^a   Gomez P ^a   Vargas, C ^a   Ortiz, S ^a   Perez Rial S ^a   Uriguen L ^a   Oliva, J M ^a   Villanueva, C ^a   Manzanares, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cerebrospinal fluid; Dementia with Lewy bodies; Neurotransmitter amino acids; Plasma

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; ASPARAGINE; ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; NEUROTRANSMITTER;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; FEMALE; HAMILTON SCALE; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LEWY BODY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PRIORITY JOURNAL;

AGE FACTORS; AGE OF ONSET; AGED; ASPARAGINE; ASPARTIC ACID; BODY MASS INDEX; BRAIN; CEREBROSPINAL FLUID; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLYCINE; HUMANS; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; NEUROTRANSMITTER AGENTS;

EID: 17644368542     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0202-3     Document Type: Article

References (34)

1. Basun H, Forssel LG, Almkvist O, Cowburn RF, Eklof R, Wimbland B, Wetterberg L (1990) Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy controls subjects. J Neural Transm (PD Sect) 2: 295-304
2. Betz AL, Goldstein GW, Katzman R (1994) Blood-brain-cerebrospinal fluid barriers. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic neurochemistry: molecular, cellular, and medical aspects, 5th ed. Raven Press, New York, pp 681-699
3. Briddon A (1996) Decision support techniques for the interpretation of quantitative amino acid data. Ann Clin Biochem 33: 227-233
4. Camu W, Billiard M, Baldy-Moulinier M (1993) Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand 88: 51-55
5. Castillo J, Dávalos A, Naviero J, Noya M (1996) Neurotoxicity amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27: 1060-1065
6. Chen N, Li B, Murphy TH, Raymond LA (2004) Site within N-Methyl-D-aspartate receptor pore modulates channel gating. Mol Pharmacol 65: 157-164
7. th ed. Oxford University Press, New York Oxford, pp 105-151
8. Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW (1996) CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology 46: 1715-1720
9. Dalla Bernardina B, Aicardi J, Goutieres F, Plouin P (1979) Glycine encephalopathy. Neuropediatrie 10: 209-225
10. Dingledine R, McBain CJ (1994) Excitatory amino acid trasmitters. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic neurochemistry: molecular, cellular, and medical aspects, 5th ed. Raven Press, New York, pp 367-387
11. Fafournoux P, Bruhat A, Jousse C (2000) Amino acid regulation of gene expression. J Neurochem 351: 1-12
12. Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L (2001) Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57: 671-675
13. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198
14. Galvin JE, Uryu K, Lee VM, Trojanowski JQ (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci USA 96: 13450-13455
15. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632-637
16. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
17. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford BA (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40: 1-8
18. Hashimoto M, Masliah E (1999) Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol 9: 707-720
19. Heidebrink JL (2002) Is dementia with Lewy bodies the second most common cause of dementia? J Geriatr Psychiatry Neurol 15: 182-187
20. Jiménez-Jiménez FJ, Molina JA, Vargas C, Gómez P, Navarro JA, Benito-León J, Ortí-Pareja M, Gasalla T, Cisneros E, Arenas J (1996) Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci 141: 39-44
21. Kim TD, Paik SR, Yang CH, Kim J (2000) Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci 9: 2489-2496
22. Kleckner NW, Dingledine R (1988) Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241: 835-837
23. Kuiper MA, Teerlink T, Visser JJ, Bergmans PL, Scheltens P, Wolters EC (2000) L-glutamate, L-arginine and L-citrulline levels in cerebrospinal fluid of Parkinson's disease, multiple system atrophy, and Alzheimer's disease patients. J Neural Transm 107: 183-189
24. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124
25. McKeith IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH (1998) What are the relations between Lewy body disease and AD? J Neural Transm [Suppl] 54: 107-116
26. O'Connor SE, Imperiali B (1996) Modulation of protein structure and function by asparagines-linked glycosylation. Chem Biol 10: 803-812
27. th ed. Raven Press, New York, pp 335-347
28. Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124
29. Smith CC, Bowen DM, Francis Pt, Snowden JS, Neary D (1985) Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiatry 48: 469-471
30. Tohgi H, Abe T, Hashiguchi K, Takahashi S, Nozaki Y, Kikuchi T (1991) A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration. Neurosci Lett 126: 155-158
31. Tohgi H, Abe T, Hashiguchi K (1993) The effect of age on concentration of aminoamines, amino acids and their related substances in cerebrospinal fluid. J Neural Transm (PD Sect) 5: 215-226
32. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H (1998) Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol (Berl) 96: 445-452
33. Walker V, Mills GA (1995) Quantitative methods for amino acid analysis in biological fluids. Ann Clin Biochem 32: 28-57
34. Yanai Y, Shibasaki T, Kohno N, Mitsui T, Nakajima H (1986) Concentrations of glycine and serine in cerebrospinal fluid during disturbed conciousness; a study of the therapeutic effect of thyrotropin-releasing, hormone on the conciousness level. Eur Neurol 25: 19-25